This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels. However, the involvement of the company should always be stated.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.
In this blog post, we will first briefly outline the procedural steps in the 510(k) review process for medical devices. However, the strategy of addressing the AI request presented in the next section of this blog post applies to all three types of 510(k)s. FDA Day (in calendar days) FDA Actions Day 1 FDA receives 510(k) submission.
There was a small mix up with communication that Oscar had bloods done at school, so we had a couple of messages saying they were doing it at home, when in fact they were doing it at school as usual during term time. This blog has been created as a way to share real stories, ideas, positivity and even sprinkle in some science.
In recent years, the use of smart labels allows the developer to convey a greater amount of information about the product to the consumers, without the need for additional packaging space. The post Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin appeared first on Blog.
Background FDA first introduced the final rule and guidance on eMDR in 2014 , which we blogged about here. For any major changes, additional time will be granted between the release of the implementation package and production deployment. User facilities are not required, but have been encouraged, to submit MDRs electronically.
As readers of our blog know, MoCRA was a significant change to regulation of cosmetics. As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.
It’s important to always be open and communicative with your travel companions, so everyone is in-tune and on track together. Aureus Medical Group travelers are covered from day one with a comprehensive perks and benefits package that includes: Low-cost, day-one health, vision, and dental. Unlimited loyalty and referral bonuses.
The survey was distributed via an email communications to ISPE members, a blog on ISPE’s website, and LinkedIn postings. In this two-part blog series, we first spotlight a summary of the survey findings of the current status for handling single-use items once they have completed their mission.
Just like no two travelers are alike, no two recruiters are the same, and you may need to work with a few before you find one with the communication, style, personality, and work ethic that meshes best with yours. Communicate quickly and clearly. . Answer: Yes, it’s perfectly okay to work with multiple recruiters!
Thanks to the clinical supply chain service companies' years of industry development and operation, there are new developments in global supply chain layout, ultra-low temperature storage and distribution management breakthroughs, and growing packaging and labeling capabilities. By Li Jie of ClinsChain
2022 ISPE China Pharmaceutical Supply Chain Summit Trudy Patterson Tue, 03/28/2023 - 09:24 iSpeak Blog iSpeak 2022 ISPE China Pharmaceutical Supply Chain Summit 28 March 2023 On 17 December 2022, more than 100 people from all over the world gathered online for the 2022 ISPE China Pharmaceutical Supply Chain Summit. By Li Jie of ClinsChain
These market developments have made modular facilities more attractive to drug manufacturers today, as these facilities can quickly switch between multiple drugs, enabling formulation and packaging in multiple formats, such as solid, liquid, semi-solid and parenteral dosage forms.
As you start to explore the process of traveling with Aureus Medical, it’s important to always communicate your anticipated travel timeline with your recruiter. Your recruiter, the Aureus Medical website, or the Aureus Medical blog page are great resources for housing tips and discounts. Are you casually looking for an assignment?
iSpeak Blog. Pfizer was able to build close to two years of supply of products for the vaccine; it had to quickly scale up for producing billions of doses in a very short period of time, so Pfizer looked to ramp up drug substance, drug product, and packaging in many sites around the world in record time. Trudy Patterson.
The guidance describes elements that would be required of VCS bodies for recognition of standards they adopt: openness (with meaningful opportunities to participate), balance (broad range of stakeholders), due process, an appeals process, and consensus.
Are they seniors interested in compliance packaging? Blogs on health topics, videos on medical advice, and newsletters with exclusive offers can entice engagement and drive traffic directly to your services and products. Or busy professionals who would love delivery service? Are they parents in need of pediatric care products?
4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). iSpeak blog. Nature Communications 12, no. iSpeak blog.
Encouraging Transparency : FDA is working closely with manufacturers to ensure clearer labeling and increased transparency regarding ingredients and nutritional information on formula packaging.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content